Kirti Shah

1.0k total citations · 1 hit paper
8 papers, 852 citations indexed

About

Kirti Shah is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Kirti Shah has authored 8 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Sensory Systems. Recurrent topics in Kirti Shah's work include Pain Mechanisms and Treatments (3 papers), Ion Channels and Receptors (3 papers) and DNA and Nucleic Acid Chemistry (2 papers). Kirti Shah is often cited by papers focused on Pain Mechanisms and Treatments (3 papers), Ion Channels and Receptors (3 papers) and DNA and Nucleic Acid Chemistry (2 papers). Kirti Shah collaborates with scholars based in Switzerland, United Kingdom and Russia. Kirti Shah's co-authors include H P Rang, Stuart Bevan, Iain F. James, Glyn A. Hughes, Sandeep S Hothi, Christopher Walpole, J.C. Yeats, Janet Winter, Elsa Phillips and Peter McIntyre and has published in prestigious journals such as Blood, Cancer Research and British Journal of Pharmacology.

In The Last Decade

Kirti Shah

8 papers receiving 818 citations

Hit Papers

Capsazepine: a competitive antagonist of the sensory neur... 1992 2026 2003 2014 1992 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kirti Shah Switzerland 5 596 417 292 242 82 8 852
Mitsuko Numazaki Japan 8 810 1.4× 572 1.4× 382 1.3× 335 1.4× 118 1.4× 10 1.1k
Dawn Zhu United States 9 605 1.0× 534 1.3× 214 0.7× 319 1.3× 141 1.7× 10 1.1k
J.C. Yeats United Kingdom 6 626 1.1× 467 1.1× 386 1.3× 328 1.4× 69 0.8× 11 1.0k
Sravan Mandadi Canada 13 540 0.9× 321 0.8× 221 0.8× 235 1.0× 115 1.4× 18 983
Chang-Joong Kang South Korea 7 845 1.4× 543 1.3× 369 1.3× 270 1.1× 101 1.2× 21 1.3k
R. J. Docherty United Kingdom 10 456 0.8× 316 0.8× 509 1.7× 422 1.7× 47 0.6× 11 884
Ilaria M. Marone Italy 14 383 0.6× 415 1.0× 250 0.9× 211 0.9× 91 1.1× 14 942
Nuria García‐Sanz Spain 7 614 1.0× 344 0.8× 242 0.8× 237 1.0× 105 1.3× 8 856
A. S. Piper United Kingdom 13 377 0.6× 196 0.5× 354 1.2× 247 1.0× 28 0.3× 14 682
G. Droogmans Belgium 12 510 0.9× 199 0.5× 435 1.5× 198 0.8× 30 0.4× 16 886

Countries citing papers authored by Kirti Shah

Since Specialization
Citations

This map shows the geographic impact of Kirti Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirti Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirti Shah more than expected).

Fields of papers citing papers by Kirti Shah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirti Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirti Shah. The network helps show where Kirti Shah may publish in the future.

Co-authorship network of co-authors of Kirti Shah

This figure shows the co-authorship network connecting the top 25 collaborators of Kirti Shah. A scholar is included among the top collaborators of Kirti Shah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirti Shah. Kirti Shah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Doran, Benjamin A., Kirti Shah, Gail Rowlinson‐Busza, et al.. (2007). Combination of the aptamer AS1411 with paclitaxel or Ara-C produces synergistic inhibition of cancer cell growth. Cancer Research. 67. 4818–4818. 5 indexed citations
2.
Shah, Kirti, et al.. (2007). Combination of the vascular disrupting agent DMXAA (AS1404) with bevacizumab and paclitaxel produces synergistic antitumor activity in lung cancer xenografts. Cancer Research. 67. 4642–4642. 4 indexed citations
3.
Shah, Kirti, et al.. (2006). AS1411, a Novel DNA Aptamer as a Potential Treatment of Acute Myelogenous Leukaemia (AML).. Blood. 108(11). 1996–1996. 2 indexed citations
4.
Bron, Romke, Laura J. Klesse, Kirti Shah, Luis F. Parada, & Janet Winter. (2003). Activation of Ras is necessary and sufficient for upregulation of vanilloid receptor type 1 in sensory neurons by neurotrophic factors. Molecular and Cellular Neuroscience. 22(1). 118–132. 82 indexed citations
5.
Savidge, Jonathan R., Clare Davis, Kirti Shah, et al.. (2002). Cloning and functional characterization of the guinea pig vanilloid receptor 1. Neuropharmacology. 43(3). 450–456. 80 indexed citations
6.
McIntyre, Peter, Linda M. McLatchie, Anne Chambers, et al.. (2001). Pharmacological differences between the human and rat vanilloid receptor 1 (VR1). British Journal of Pharmacology. 132(5). 1084–1094. 166 indexed citations
7.
Shah, Kirti, et al.. (1996). Preliminary experience with use of a selective 5HT3 receptor antagonist (ondansetron) to prevent high dose chemotherapy induced emesis.. PubMed. 33(1). 17–20. 3 indexed citations
8.
Bevan, Stuart, Sandeep S Hothi, Glyn A. Hughes, et al.. (1992). Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. British Journal of Pharmacology. 107(2). 544–552. 510 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026